Cefepime vs. ceftazidime treatment of pyelonephritis: A European, randomized, controlled study of 300 pediatric cases

Pediatric Infectious Disease Journal

Volumn 17, Issue 7, 1998, Pages 639-644

  Schaad, Urs B ^a,i   Eskola, Juhani ^b   Kafetzis, Dimitris ^c   Fishbach, Michel ^e   Ashkenazi, Shai ^f   Syriopoulou, Vassiliki ^d   Boulesteix, Jean ^g   De Pril, Veerle ^h   Grès, Jean Jacques ^h   Rollin, Christian ^h  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^g DUPUYTREN UNIVERSITY HOSPITAL   (France)

^h BRISTOL MYERS SQUIBB   (United States)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cefepime; Ceftazidime; Pyelonephritis; Treatment

Indexed keywords

CEFEPIME; CEFTAZIDIME; COTRIMOXAZOLE; CEPHALOSPORIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; ESCHERICHIA COLI; EUROPE; FEMALE; HUMAN; INFANT; KLEBSIELLA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; INTRAVENOUS DRUG ADMINISTRATION; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD;

ADMINISTRATION, ORAL; CEFTAZIDIME; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAVENOUS; MALE; PYELONEPHRITIS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0032111944     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199807000-00012     Document Type: Article

References (14)

1. Wientzen RL, McCracken GH, Petruska ML, Swinson SG, Kaisjer B, Hanson LA. Localization and therapy of urinary tract infections in children. Pediatrics 1979;63:467-74.
2. Ashkenazi S, Even-Tov S, Samra Z, Dinari G. Uropathogens of various childhood populations and their antibiotic susceptibility. Pediatr Infect Dis J 1991;10:742-6.
3. Rubin RH, Shapiro ED, Andriole VT, Davis RJ, Stamm WE. Evaluation of new anti-infective drugs for the treatment of urinary tract infection. Clin Infect Dis 1992;15:S216-27.
4. Sanders CC. Cefepime: the next generation? 1993;17:369-79.
5. Rusconi F, Assael BM, Florioli A, Zafferoni G. Ceftazidime in the treatment of pediatric patients with severe urinary tract infections due to Pseudomonas spp. Antimicrob Agents Chemother 1984;25:395-7.
6. Coding symbols for thesaurus of adverse reaction terms (COSTART). 3rd ed. Springfield, VA: National Technical Information Service, 1989.
7. Blackwelder WC. "Proving the null hypothesis" in clinical trial. Control Clin Trials 1982;3:345-53.
8. Holloway WJ, Palmer D. Clinical applications of a new parenteral antibiotic in the treatment of severe bacterial infections. Am J Med 1996:100(Suppl 6A):S54-9.
9. Sharifi R, Geckler R, Childs S. Treatment of urinary tract infections: selecting an appropriate broad-spectrum antibiotic for nosocomial infections. Am J Med 1996;100(Suppl 6A):S76-82.
10. Sáez-Llorens X, Castaño E, Garcia R, et al. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother 1995;39:937-40.
11. Cordonnier C, Herbrecht R, Pico JL, et al. Cefepime/amikacin vs. ceftazidime as empirical therapy for febrile episodes in neutropenic patients: a comparative study. Clin Infect Dis 1997;24:41-51.
12. Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am J Med 1996;100(Suppl 6A):S83-9.
13. Schwartz R, Das-Young LR, Ramirez-Ronda C. Current and future management of serious skin and skin-structure infections. Am J Med 1996;100(Suppl 6A):S90-5.
14. McCabe R, Chirurgi V, Farkas SA, Haddow A, Heinz G, Greene S. A new therapeutic option for the treatment of pneumonia. Am J Med 1996;100(Suppl 6A):S60-7.